FibroGen (FGEN) PT Lowered to $2 at Goldman Sachs
Tweet
Share
E-mailGet Alerts FGEN Hot Sheet
Price: $9.71 --0%
Rating Summary:
4 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 59
Rating Summary:
4 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 59
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi lowered the price target on FibroGen (NASDAQ: FGEN) to $2.00 (from $16.00) while maintaining a Sell rating.
You May Also Be Interested In
- XPeng (XPEV) PT Lowered to $15 at US Tiger Securities
- BJ's Wholesale (BJ) PT Raised to $115 at UBS as Business Model 'Remains Relevant'
- Insmed (INSM) PT Raised to $195 at Mizuho
Create E-mail Alert Related Categories
Analyst PT Change, Hot CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
